TY - JOUR T1 - Modelling of the second (and subsequent) waves of the coronavirus epidemic. Spain and Germany as case studies JF - medRxiv DO - 10.1101/2020.06.12.20129429 SP - 2020.06.12.20129429 AU - Francisco de Castro Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/07/28/2020.06.12.20129429.abstract N2 - The first wave of the coronavirus pandemic is waning in many countries. Some of them are starting to lift the confinement measures adopted to control it, but there is considerable uncertainty about if it is too soon and it may cause a second wave of the epidemic. To explore this issue, I fitted a SEIR model with time-dependent transmission and mortality rates to data from Spain and Germany as contrasting case studies. The model reached an excellent fit to the data. I then simulated the post-confinement epidemic under several scenarios. The model shows that (in the absence of a vaccine) a second wave is likely inevitable and will arrive soon, and that a strategy of adaptive confinement may be effective to control it. The model also shows that just a few days delay in starting the confinement may have caused and excess of thousands of deaths in Spain.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNAFunding StatementNAAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are publicly available. See links below. Custom code is available at: https://www.mathworks.com/matlabcentral/fileexchange/77428-fitseir https://www.ecdc.europa.eu/en/publications-data/download-todays-data-geographic-distribution-covid-19-cases-worldwide https://github.com/CSSEGISandData/COVID-19 ER -